News & Events
Report: Realizing the Potential of the Science Community to Support Rising Generations in STEM
This report, developed as part of the Aspen Institute Science & Society Program’s 2025 roundtable series, synthesizes insights from practitioners in K–12 education, higher education, science research, professional associations, science communication, and civic science. The [read more]
Realizing the Potential of the Science Community to Support Rising Generations in STEM
A recent report by the Science & Society Program discusses fundamental questions about recent and rapid policy shifts within the federally-funded research and higher education ecosystems, as well as our our nation’s social contract for [read more]
Request for Proposals: Third Annual Renée Fleming Neuroarts Investigator Awards to Advance Arts and Health Research
NeuroArts Blueprint
The Renée Fleming Foundation in partnership with the NeuroArts Blueprint Initiative is offering year two of the Renée Fleming Neuroarts Investigator Awards. The Awards support innovative and collaborative research by early career researchers, [read more]
Press Release: NeuroArts Blueprint Initiative Launches Nationwide Network of Community Neuroarts Coalitions
NeuroArts Blueprint
On November 12, the NeuroArts Blueprint Initiative launched the Community Neuroarts Coalitions (CNC) Network to support 11 communities across the U.S. using the power of the arts to improve health and well-being. [read more]
News Article: Medicare Can’t Afford Not To Cover Ozempic
A decision for whether Medicare will cover a revolutionary new class of weight-loss treatments, which include drugs like Zepbound and Wegovy, could be imminent, according to Dr. Mehmet Oz, head of the Centers for Medicare [read more]
News Article: CMS Administrator Dr. Oz on GLP-1 for weight loss in Medicare: You’ll be hearing more soon
CMS Administrator Dr. Mehmet Oz addressed the rising discussion around covering GLP-1 medications (like Ozempic and Wegovy) for weight loss under Medicare. Citing “a lot of action” in the space, Oz confirmed that a decision [read more]
